{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "a-synuclein",
        "Protein_Change": {
          "ref": "Normal",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "a-synuclein Normal"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the role of a-synuclein in Parkinson's disease (PD) and its involvement in dopaminergic cell death. The mechanisms by which this occurs are unknown but the focus is on transcriptional changes in neuroblastoma cell lines.",
          "judgment": "Yes",
          "judgment_basis": "The paper discusses the role of a-synuclein in PD and its involvement in dopaminergic cell death."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses gene expression assays to investigate transcriptional changes.",
          "judgment": "Yes",
          "judgment_basis": "Gene expression assays are commonly used to study gene regulation and transcription, and they effectively model or reflect the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "3a. Basic Controls and Replicates",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were *both* 'Normal/Negative/Wild type' **AND** 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "sub_step_name": "3c. Variant Controls (if basic controls/replicates were sufficient in 3a)",
              "questions": [
                {
                  "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "sub_step_name": "4a. Statistical Analyses",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant? (OddsPath refers to a quantitative measure of pathogenicity likelihood from functional assays)",
                  "answer": "Yes"
                }
              ]
            },
            {
              "sub_step_name": "4c. Correlate OddsPath (if statistical analyses were sufficient)",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": "Not specified"
                },
                {
                  "question": "What is the OddsPath value calculated in the paper for this variant?",
                  "answer": "Not specified"
                }
              ]
            }
          ]
        }
      ],
      "functional_evidence_summary": "The paper uses gene expression assays to investigate transcriptional changes in neuroblastoma cell lines with a focus on Parkinson's disease and a-synuclein. Basic controls, variant controls, and statistical analyses are all present in the study. However, specific details about the number of total controls used or the calculated OddsPath for this variant were not provided.",
      "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    }
  ]
}